A Pfizer colleague since 2007, Beverley provides European regulatory strategic advice and support for vaccines. Her work includes day to day resolution of program issues for clinical and regulatory activities within the Specialty Care unit.
As a Fellow, Beverley will be working with the Infectious Diseases Institute (IDI). From 2012-2013, various Fellows will work with the IDI research team in Uganda to assess and strengthen their capacity to run Phase I-IV clinical trials following global standards. They will assist on all aspects of managing trials including developing operating procedures, implementing data and quality measures, and training staff. Fellows' work will contribute to IDI's goal of being the premier service provider for patients with infectious diseases.
Beverley uses her professional and life skills to support the provision of education and healthcare in Northern Mozambique as a Trustee of the Mandawilderness Community Trust. She anticipates that her Fellowship will help her to learn a wider and more flexible way of working in resource constrained environments. And, she hopes to be able apply these lessons to her work at Pfizer. Beverly also hopes to gain additional negotiating and leadership experience.
Accordia Global Health Foundation is working to overcome the burden of infectious diseases by building health care capacity and strengthening academic medical institutions in Africa. Accordia does this through establishing Centers of Excellence for advancing and promoting the highest quality standards of infectious disease care through original research and health care workforce training. The Infectious Disease Institute (IDI) in Kampala, Uganda is Accordia's flagship program. Created via public-private partnership and multi-institutional collaboration, IDI serves as a model for sustainable, locally-owned, regional Centers of Excellence. IDI offers high quality training for health workers; research on best practices related to HIV in low resource settings; and advanced clinical services that support the development of new models of care.